Order winFiled on NSE ·
Canarys Automations Limited secures US$36,000 AI platform contract from Tenpoint Therapeutics
Canarys Automations · IT - Software
Key highlights
- Canarys Automations Limited awarded a 36-month contract by Tenpoint Therapeutics for Auryis AI-Enabled Social Media Monitoring module
- Contract value is US$36,000; engagement includes partnership with Eversana Life Science Services LLC to service the contract
- First commercial sale of Canarys' AI product Auryis, supporting pharma industry compliance and patient safety through social media monitoring
Original filing
Awarding of order(s)/contract(s)
Read the filing on NSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Knowledge Marine
Engineering Services
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other order win filings this fortnight
- Order winRailtel Corporation of IndiaRailTel secures major order from Andhra Pradesh Technology Services for AI platform
- Order winLeapfrog Engineering ServicesLeapfrog Engineering Services receives ₹22.05 crore LOI from KPTCL
- Order winKratikal TechKratikal Tech Ltd's subsidiary receives ₹3.16 crore purchase order for OT cybersecurity
- Order winPremier ExplosivesPremier Explosives Limited receives $33.6M export order for defence explosives
- Order winTexmaco Rail & EngineeringTexmaco Rail & Engineering Ltd receives LOIs worth Rs. 230.58 Crores for wagon supply
- Order winAmeenji RubberAmeenji Rubber Limited receives ₹13.15 crore purchase order from Central Railway
Potential multibaggers · Q2 FY27
Potential multibaggers in IT - Software
on management's own guidance
- Strong growth2
- Strong growth1
- Fractal AnalyticsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
